Inhibrx Biosciences Insider Bought Shares Worth $1,523,620, According to a Recent SEC Filing
JMP Securities Maintains Inhibrx Biosciences(INBX.US) With Hold Rating
JMP Securities Sticks to Their Hold Rating for Inhibrx Biosciences Inc (INBX)
The Recent Drop in Prices Must Have Disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) Institutional Investors Who Own 43% of the Shares
Inhibrx Biosciences | 10-Q: Quarterly report
Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Third Quarter 2024 Financial Results